Trials / Active Not Recruiting
Active Not RecruitingNCT05007093
Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
An Exploratory Study on Efficacy of Anlotinib Hydrochloride in the Treatment of Locally Advanced or Metastatic Differentiated Thyroid Cancer
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Yansong Lin · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of anlotinib in patients with locally advanced or metastatic differentiated thyroid cancer resistant to iodine therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anlotinib hydrochloride | If intolerance occurs, the dose can be downregulated |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2024-11-01
- Completion
- 2025-06-30
- First posted
- 2021-08-16
- Last updated
- 2024-11-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05007093. Inclusion in this directory is not an endorsement.